278
Views
7
CrossRef citations to date
0
Altmetric
Lens

Expression of α-Klotho Is Downregulated and Associated with Oxidative Stress in the Lens in Streptozotocin-induced Diabetic Rats

, , &
Pages 482-489 | Received 24 Mar 2020, Accepted 30 Jul 2020, Published online: 14 Aug 2020

References

  • Pollreisz A, Schmidt-Erfurth U. Diabetic cataract-pathogenesis, epidemiology and treatment. J Ophthalmol. 2010;2010:608751.
  • Kaczmarczyk-Sedlak I, Folwarczna J, Sedlak L, Zych M, Wojnar W, Szuminska I, Wygledowska-Promienska D, Mrukwa-Kominek E. Effect of caffeine on biomarkers of oxidative stress in lenses of rats with streptozotocin-induced diabetes. Arch Med Sci. 2019;15:1073–80.
  • Wang F, Ma J, Han F, Guo X, Meng L, Sun Y, Jin C, Duan H, Li H, Peng Y. DL-3-n-butylphthalide delays the onset and progression of diabetic cataract by inhibiting oxidative stress in rat diabetic model. Sci Rep. 2016;6:19396.
  • Nita M, Grzybowski A. The role of the reactive oxygen species and oxidative stress in the pathomechanism of the age-related ocular diseases and other pathologies of the anterior and posterior eye segments in adults. Oxid Med Cell Longev. 2016;2016:3164734.
  • Wang Y, Sun Z. Current understanding of klotho. Ageing Res Rev. 2009;8:43–51.
  • Maltese G, PM P, Rizzo B, Srivastava S, Gnudi L, GE M, RC S. The anti-ageing hormone klotho induces Nrf2-mediated antioxidant defences in human aortic smooth muscle cells. J Cell Mol Med. 2017;21:621–27.
  • Oh HJ, Oh H, Nam BY, You JS, Ryu DR, Kang SW, Chung YE. The protective effect of klotho against contrast-associated acute kidney injury via the antioxidative effect. Am J Physiol Renal Physiol. 2019;317:F881–F889.
  • Moos WH, Faller DV, Glavas IP, Harpp DN, Kanara I, Mavrakis AN, Pernokas J, Pernokas M, Pinkert CA, Powers WR, et al. Klotho pathways, myelination disorders, neurodegenerative diseases, and epigenetic drugs. Biores Open Access. 2020;9:94–105.
  • Ravikumar P, Li L, Ye J, Shi M, Taniguchi M, Zhang J, Kuro-o M, Hu MC, Moe OW, Hsia CC. alphaKlotho deficiency in acute kidney injury contributes to lung damage. J Appl Physiol (1985). 2016;120:723–32.
  • Zhang Y, Wang L, Wu Z, Yu X, Du X, Li X. The expressions of Klotho family genes in human ocular tissues and in anterior lens capsules of age-related cataract. Curr Eye Res. 2017;42:871–75.
  • Jin SL, Zhang Y, Chen ZH, Qian DW, Qine YJ, Yongjie Q, He SK, Guo HK. Epigenetic changes of the Klotho gene in age-related cataracts. Eur Rev Med Pharmacol Sci. 2015;19:2544–53.
  • Chen Y, Sun XB, Lu HE, Wang F, Fan XH. Effect of luteoin in delaying cataract in STZ-induced diabetic rats. Arch Pharm Res. 2017;40:88–95.
  • Bahmani F, Bathaie SZ, Aldavood SJ, Ghahghaei A. Glycine therapy inhibits the progression of cataract in streptozotocin-induced diabetic rats. Mol Vis. 2012;18:439–48.
  • Fan J, Lerner J, Wyatt MK, Cai P, Peterson K, Dong L, Wistow G. The klotho-related protein KLPH (lctl) has preferred expression in lens and is essential for expression of clic5 and normal lens suture formation. Exp Eye Res. 2018;169:111–21.
  • Lee JM, Johnson JA. An important role of Nrf2-ARE pathway in the cellular defense mechanism. J Biochem Mol Biol. 2004;37:139–43.
  • Kaspar JW, Niture SK, Jaiswal AK. Nrf2: iNrf2(Keap1) signaling in oxidative stress. Free Radic Biol Med. 2009;47:1304–09.
  • Zeldich E, Chen CD, Colvin TA, Bove-Fenderson EA, Liang J, Tucker Zhou TB, Harris DA, Abraham CR. The neuroprotective effect of Klotho is mediated via regulation of members of the redox system. J Biol Chem. 2014;289:24700–15.
  • Kyselova Z, Stefek M, Bauer V. Pharmacological prevention of diabetic cataract. J Diabetes Complications. 2004;18:129–40.
  • Thiraphatthanavong P, Wattanathorn J, Muchimapura S, Thukham-mee W, Lertrat K, Suriharn B. The combined extract of purple waxy corn and ginger prevents cataractogenesis and retinopathy in streptozotocin-diabetic rats. Oxid Med Cell Longev. 2014;2014:789406.
  • Zhang S, Chai FY, Yan H, Guo Y, Harding JJ. Effects of N-acetylcysteine and glutathione ethyl ester drops on streptozotocin-induced diabetic cataract in rats. Mol Vis. 2008;14:862–70.
  • Tirgan N, Kulp GA, Gupta P, Boretsky A, Wiraszka TA, Godley B, Tilton RG, Motamedi M. Nicotine exposure exacerbates development of cataracts in a type 1 diabetic rat model. Exp Diabetes Res. 2012;2012:349320.
  • Wang MX, Zhao J, Zhang H, Li K, Niu LZ, Wang YP, Zheng YJ. Potential Protective and Therapeutic Roles of the Nrf2 Pathway in Ocular Diseases: an Update. Oxid Med Cell Longev. 2020;2020:9410952.
  • Aminzadeh MA, Nicholas SB, Norris KC, Vaziri ND. Role of impaired Nrf2 activation in the pathogenesis of oxidative stress and inflammation in chronic tubulo-interstitial nephropathy. Nephrol Dial Transplant. 2013;28:2038–45.
  • Li M, Yu H, Pan H, Zhou X, Ruan Q, Kong D, Chu Z, Li H, Huang J, Huang X, et al. Nrf2 suppression delays diabetic wound healing through sustained oxidative stress and inflammation. Front Pharmacol. 2019;10:1099.
  • Jimenez-Osorio AS, Picazo A, Gonzalez-Reyes S, Barrera-Oviedo D, Rodriguez-Arellano ME, Pedraza-Chaverri J. Nrf2 and redox status in prediabetic and diabetic patients. Int J Mol Sci. 2014;15:20290–305.
  • Shenvi SV, Smith E, Hagen TM. Identification of age-specific Nrf2 binding to a novel antioxidant response element locus in the Gclc promoter: a compensatory means for the loss of glutathione synthetic capacity in the aging rat liver? Aging Cell. 2012;11:297–304.
  • Zhong Q, Mishra M, Kowluru RA. Transcription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2013;54:3941–48.
  • Rojo AI, Sagarra MR, Cuadrado A. GSK-3beta down-regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress. J Neurochem. 2008;105:192–202.
  • Salazar M, Rojo AI, Velasco D, de Sagarra RM, Cuadrado A. Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2. J Biol Chem. 2006;281:14841–51.
  • Ji B, Wei H, Ding Y, Liang H, Yao L, Wang H, Qu H, Deng H. Protective potential of klotho protein on diabetic retinopathy: evidence from clinical and in vitro studies. J Diabetes Investig. 2019;11:162–169.
  • Turan K, Ata P. Effects of intra- and extracellular factors on anti-aging klotho gene expression. Genet Mol Res. 2011;10:2009–23.
  • Lee CT, Capodieci P, Osman I, Fazzari M, Ferrara J, Scher HI, Cordon-Cardo C. Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer. Clin Cancer Res. 1999;5:977–83.
  • Liu Y, Sanoff HK, Cho H, Burd CE, Torrice C, Ibrahim JG, Thomas NE, Sharpless NE. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009;8:439–48.
  • Melk A, Schmidt BM, Takeuchi O, Sawitzki B, Rayner DC, Halloran PF. Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidney. Kidney Int. 2004;65:510–20.
  • Altun E, Yazici H, Arslan E, Tulaci KG, Erken HA. The impact of type II diabetes on tongue dysplasia and p16-related aging process: an experimental study. Anal Cell Pathol (Amst). 2019;2019:3563215.
  • Yamashiro Y, Sasaki H, Ibaraki N, Nagai K, Kawakami Y, Yaguchi H, Fujita N, Osada H, Sasaki K. Cyclin-dependent kinase inhibitor p16 and p21 expression, and cell cycle change in human lens epithelial cell line SRA 01/04 following contact inhibition in normal culture. Ophthalmic Res. 2011;46:38–43.
  • Ito S, Fujimori T, Hayashizaki Y, Nabeshima Y. Identification of a novel mouse membrane-bound family 1 glycosidase-like protein, which carries an atypical active site structure. Biochim Biophys Acta. 2002;1576:341–45.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.